Squamous metaplasia is increased in the bronchial epithelium of smokers with chronic obstructive pulmonary disease

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Rigden, Helen M ^a   Alias, Ahmad ^a   Havelock, Thomas ^a,b   O'Donnell, Rory ^a   Djukanovic, Ratko ^a,b   Davies, Donna E ^a,b   Wilson, Susan J ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; KI 67 ANTIGEN; PROTEIN P53; TUMOR MARKER;

ADULT; ARTICLE; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CARCINOGENESIS; CELL DIFFERENTIATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SMOKING; SQUAMOUS CELL METAPLASIA; SQUAMOUS EPITHELIUM; ADVERSE EFFECTS; BRONCHUS; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPLICATION; DRUG EFFECTS; EPITHELIUM CELL; METAPLASIA; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

BRONCHI; CASE-CONTROL STUDIES; EPITHELIAL CELLS; FEMALE; HUMANS; MALE; METAPLASIA; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 84973320442     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156009     Document Type: Article

References (52)

1. Cosio M, Ghezzo H, Hogg JC, Corbin R, Loveland M, Dosman J, et al. The relationship between structural changes in small airways and pulmonary function tests. N Engl J Med 1977; 298: 1277-1281.
2. Mathe G, Gouveia J, Hercend T, Gros F, Dorval T, Hazon J, et al. Correlation between precancerous bronchial metaplasia and cigarette consumption, and preliminary results of retinoid treatment. Cancer Detect Prev 1982; 5: 461-466. PMID: 7182070
3. Peters EJ, Morice R, Benner SE, Lippman S, Lukeman J, Lee JS, et al. Squamous metaplasia of the bronchial mucosa and its relationship to smoking. Chest 1993; 103: 1429-1432. PMID: 8486022
4. Barsky SH, Roth MD, Kleerup EC, Simmons M, Tashkin DP. Histopathological and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine and/or tobacco. J Natl Cancer Inst 1998; 90: 1198-1205. PMID: 9719080
5. Jetten AM. Multistep process of squamous differentiation of tracheobronchial epithelial cells in vitro. Analogy with epidermal differentiation. Environ Health Perspect 1989; 80: 149-160. PMID: 2647475
6. Leube RE, Rustad TJ. Squamous cell metaplasia in the human lung: molecular characteristics of epithelial stratification. Virchows Arch B Cell Pathol Incl Mol Pathol 1991; 61: 227-253. PMID: 1723555
7. Wistuba II, Behrens C, Milchgrub S, Bryant D, Humg J, Minna JD, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 1999; 18: 643-650. PMID: 9989814
8. Bertram JF, Rogers AW. Recovery of bronchial epithelium on stopping smoking. Br Med J 1981; 283:1567-1569.
9. Breuer RH, Pasic A, Smit EF, van Vilet E, Noordegraaf AV, Risse EJ, et al. The natural course of preneoplastic lesions in bronchial epithelium. Clin Can Res 2005; 11: 537-543.
10. George PJ, Banerjee AK, Read CA, O'Sullivan C, Falzon M, Pezzella F, et al. Surveillance for the detection of early lung cancer in patients with bronchial dysplasia. Thorax 2007; 62: 43-50. PMID: 16825337
11. Lapperre TS, Sont JK, van Schadewijk A, Gosman MME, Postma DS, Bajema IM, et al. GLUCOLD study group. Smoking cessation and bronchial epithelial remodelling in COPD: a cross-sectional study. Respir Res 2007; 8: 85 PMID: 18039368
12. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumours and cultured cells. Cell 1982; 31: 11-24. PMID: 6186379
13. Athanassiadou P, Psyhoyou H, Kyrkou K, Athanassiades P, Moulopoulos S. Expression of keratins and carcinoembryonic antigen in bronchial squamous metaplasia and lung carcinomas. Acta Cytol 1995; 39: 1161-1166. PMID: 7483992
14. Fisseler-Eckhoff A, Erfkamp S, Muller K-M. Cytokeratin expression in pre-neoplastic lesions and early squamous cell carcinoma of the bronchi. Pathol Res Pract 1996; 192: 552-556. PMID: 8857642
15. Wong Y-C, Kakefuda M, Bernal SD. A new membrane marker for commitment of the human bronchial epithelial cells to terminal squamous differentiation. In Vivo 1997; 11: 495-498.
16. Said JW, Nash G, Sassoon AF, Shintaku IP, Banks-Schlegel S. Involucrin in lung tumours. A specific marker for squamous differentiation. Lab Invest 1983; 49: 563-568. PMID: 6195449
17. Godtfredson NS, Prescott E, Osler M. Effect of smoking reduction on lung cancer risk. JAMA 2005; 294: 1505-1510. PMID: 16189363
18. Rooney C, Sethi T. The epithelial cell and lung cancer: the link between chronic obstructive pulmonary disease and lung cancer. Respiration 2011; 81: 89-104. doi: 10.1159/000323946 PMID: 21311210
19. Dubey S, Powell CA. Update in lung cancer 2007. Am J Respir Crit Care Med 2008; 177: 941-946. doi: 10.1164/rccm.200801-107UP PMID: 18434333
20. Caramori G, Casolari P, Cavallesco GN, Giuffre S, Adcock I, Papi A. Mechanisms involved in lung cancer development in COPD. Int J Biochem Cell Biol 2011; 43: 1030-1044. doi: 10.1016/j.biocel.2010.08.022 PMID: 20951226
21. Koshiol J, Rotunno M, Consonni D, Pesatori AC, De Matteis S, Goldstein AM, et al. Chronic obstructive pulmonary disease and aletred risk of lung cancer in a population-based case-controlled study. PLoS One 2009; 4: e7380. doi: 10.1371/journal.pone.0007380 PMID: 19812684
22. Brennar DR, McLaughin JR, Hung RJ. Previous lung disease and lung cancer risk; a systematic review and meta-analysis. PLoS One 2011; 6: e17479. doi: 10.1371/journal.pone.0017479 PMID: 21483846
23. Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med 1986; 105: 503-507. PMID: 3752756
24. Tockman MS, Anthonisen NR, Wright EC, Donithan MG. Airways obstruction and the risk of lung cancer. Ann Intern Med 1987; 106: 512-518. PMID: 3826952
25. Papi A, Caramori G, Guzzinati I, Boschetto P, Ravenna F, Calia N, et al. COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax 2004; 59: 679-681. PMID: 15282388
26. De Torres JP, Marin JM, Casanova C, Cote C, Carrizo S, Cordoba-Lanus E, et al. Lung cancer in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011; 184: 913-919. doi: 10.1164/rccm.201103-0430OC PMID: 21799072
27. Yao H, Rahman I. Current concepts on the role of inflammation in COPD and lung cancer. Curr Opin Pharmacol 2009; 9: 375-383. doi: 10.1016/j.coph.2009.06.009 PMID: 19615942
28. Barnes PJ, Adcock IM. Chronic obstructive pulmonary diseases and lung cancer: a lethal association. Am J Resp Crit Care Med 2011; 184: 866-867. doi: 10.1164/rccm.201108-1436ED PMID: 22003145
29. Houghton AM, Mouded M, Shapiro SD. Common origins if lung cancer and COPD. Nat Med 2008; 14: 1023-1024. doi: 10.1038/nm1008-1023 PMID: 18841139
30. Wasswa-Kintu S, Gan WQ, Man SFP, Pare PD, Sin DD. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 2005; 60: 570-575. PMID: 15994265
31. Balkwill F, Mantovani A. Inflammation and cancer; back to Virchow? Lancet 2001; 357: 539-545. PMID: 11229684
32. Merrifield J, O'Donnell R, Davies DE, Djukanovic R, Wilson SJ. A panel of antibodies for identifying squamous metaplasia in endobronchial biopsies from smokers. Biotech Histochem 2011; 86: 340-4. doi: 10.3109/10520295.2010.502844 PMID: 20662603
33. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI / WHO workshop report. Bethesda, National Heart, Lung and Blood Institute, April 2001 updated 2013.www.goldcopd.org
34. O'Donnell RA, Peebles C, Ward JA, Daraker A, Angco G, Broberg P, et al. relationship between peripheral airway dysfunction, airway obstruction and neutrophilic inflammation in COPD. Thorax 2004; 59: 837-842. PMID: 15454648
35. Puddicombe SM, Polosa R, Richter A, Krishna MT, Howarth PH, Holgate ST, et al. Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J 2000; 14: 1362-1374. PMID: 10877829
36. Araya J, Cambier S, Markovics JA, Wolters P, Jablons D, Hill A, et al. Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients. J Clin Invest 2007; 117: 3551-3562. PMID: 17965775
37. Shaykhiev R, Zuo W-L, Chao I, Fukui T, Witover B, Brekman A, et al. EGF shifts human airway basal cell fate toward a smoking-associated airway epithelial phenotype. PNAS 2013; 110: 12102-12107. doi: 10.1073/pnas.1303058110 PMID: 23818594
38. O'Donnell R, Richter A. Ward J, Angco G, Mehta A, Rousseau K, et al. Expression of ErbB receptors and mucins in the airways of ling term current snokers. Thorax 2004; 59: 1032-1040. PMID: 15563701
39. Stockley RA, Sha J, Whitfiled AGW, Whitehead TP, Clarke CA, Burnett D. Effect of cigarette smoking, pulmonary inflammation and lung disease on concentrations of carinoembryonic antigen in serum and secretions. Thorax 1986; 41: 17-24. PMID: 3704962
40. Bulut I, Arbak P, Coskan A, Balbay O, Annakkaya AN, Yavuz O, et al. Comparison of serum CA 19.9, CA 125 and CEA levels with severity of chronic obstructive pulmonary disease. Med Princ Pract 2009; 18: 289-293. doi: 10.1159/000215726 PMID: 19494536
41. Chang F, Syrjänen A, Tervahauta A, Syrjänen K. Tumourgenesis associated with the p53 tumour suppressor gene. Br J Cancer 1993; 68: 653-661. PMID: 8398688
42. Bennet WP, Colby TV, Travis WD, Borkowski A, Jones RT, Lane DP, et al. p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res 1993; 53: 4817-4822. PMID: 8402667
43. Klein N, Vignaud JM, Sadmi M, Plenat F, Borelly J, Duprez A, et al. Squamour metaplasia expression of proto-oncogenes and p53 in lung cancer patients. Lab Invest 1993; 68: 26-32. PMID: 8423673
44. Boers JE, Ten Velde GPM, Thunnissen FBJM. P53 in squamous metaplasia: a marker for risk of respiratory tract carcinoma. Am J Respir Crit Care Med 1996; 153: 411-416. PMID: 8542151
45. Rusch V, Klimstra D, Linkov I, Dmitrovsky E. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia, and coexpression precedes squamous cell carcinoma development. Cancer Res 1995; 55; 1365-1372. PMID: 7882337
46. Ponticiello A, Barra E, Giani U, Bocchino M, Sanduzzi A. p53 immunohistochemistry can identify bronchial dysplastic lesions proceeding to lung cancer: a prospective study. Eur Respir J 2000; 15: 547-552. PMID: 10759451
47. Anthonisen NR, Skeans MA, Wise RA, Manreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5 year mortality. Anns Int Med 2005; 142: 233-239.
48. Dragnev KH, Stover D, Dmitrovsky E. Lung cancer prevention; the guidelines. Chest 2003; 123: 60s-71s. PMID: 12527565
49. Parimon T, Chien JW, Bryson CL, McDonell MB, Udris EM, Au DH. Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 712-719. PMID: 17185647
50. Paris C, Benichou J, Bota S, Sagnier S, Metayer J, Eloy S, et al. Occupational and nonoccupational factors associated with high grade bronchial pre-invasive lesions. Eur Respir J 2003; 21: 32-341.
51. Haussinger K, Becker H, Stanzel F, Kreuzer A, Schmidt B, Strausz J, et al. Autofluorescence bronchoscopy with white light bronchoscopy compared with white light bronchoscopy alone for the detection of precancerous lesions: a European randomized controlled multicenter trial. Thorax 2005; 60:496-503. PMID: 15923251
52. Loewen G, Natarajan N, Tan D, Nava E, Klippenstein D, Mahoney M, et al. Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment. Thorax 2007; 62:335-340. PMID: 17101735